Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis

PURPOSE: Gliosarcoma is a histologic variant of glioblastoma (GBM), and like GBM carries a poor prognosis. Median survival is less than one (1) year with less than 5% of patients alive after 5 years. Although there is no cure, standard treatment includes surgery, radiation and chemotherapy. While ve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurooncol
Main Authors: Lowder, Lindsey, Hauenstein, Jennifer, Woods, Ashley, Chen, Hsiao-Rong, Rupji, Manali, Kowalski, Jeanne, Olson, Jeffrey J., Saxe, Debra, Schniederjan, Matthew, Neill, Stewart, Weinberg, Brent, Sengupta, Soma
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2019
Assuntos:
Laboratory Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591191/
https://ncbi.nlm.nih.gov/pubmed/31073965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-019-03184-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados